Business
Alkermes to Take Part in the Fourth Annual Evercore ISI HealthCONx Conference
DUBLIN, Nov. 24, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the fourth annual
About this update from Alkermes Plc
[{"type":"text","content":"DUBLIN, Nov. 24, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the fourth annual Evercore ISI HealthCONx Conference on Thursday, Dec. 2, 2021 at 10:30 a.m. ET (3:30 p.m. GMT). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.\nAbout Alkermes plc\nAlkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com. \nContact:Alex BraunInvestor Relations+1 781 296 8493\n\n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-take-part-in-the-fourth-annual-evercore-isi-healthconx-conference-301431308.html\nSOURCE Alkermes plc","length":3306,"tagName":"div"}]